# Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine

Study · id `cardio:ct-nct04181996` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04181996](<https://clinicaltrials.gov/study/NCT04181996>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04181996

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.

## Technical summary

Registry record NCT04181996. Randomized; quadruple masking; primary purpose treatment. Start 2020-08-01 (actual); primary completion 2025-12-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 115 participants (enrolled count; ClinicalTrials.gov record NCT04181996, source copy `cardio:ctgov-nct04181996-2026-05-01`, retrieved 2026-10-26)
- Started: 2020-08-01 (actual) (ClinicalTrials.gov record NCT04181996, source copy `cardio:ctgov-nct04181996-2026-05-01`, retrieved 2026-10-26)
- Primary completion: 2025-12-16 (actual) (ClinicalTrials.gov record NCT04181996, source copy `cardio:ctgov-nct04181996-2026-05-01`, retrieved 2026-10-26)
- Completion: 2025-12-16 (actual) (ClinicalTrials.gov record NCT04181996, source copy `cardio:ctgov-nct04181996-2026-05-01`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT04181996, source copy `cardio:ctgov-nct04181996-2026-05-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04181996-2026-05-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
- Acronym: CADENCE
- Condition: Cardiovascular Diseases
- Condition: Atherosclerosis
- Condition: Inflammation
- Condition: Diabetes
- Intervention (Drug): Colchicine Oral Product
- Intervention (Drug): Placebo oral capsule
- Lead sponsor: Ottawa Heart Institute Research Corporation
- Lead sponsor class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

## Provenance

Content hash: cc896e37e98c1cc8976bdfe05b7fb616eea15ee1fbb2d7f69a546cf990d28ba2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
